Sheng L

ORCID: 0000-0002-5327-8933 · 4 papers in corpus
2020
Cell cycle (Georgetown, Tex.) ·doi:10.1080/15384101.2020.1831254

Pancreatic cancer (PC) is a leading cause of cancer mortality and is expected to continue increasing incidence. Abnormally expressed microRNAs have been demonstrated tightly correlated with the development and progression of PC. However, th…

2018
Experimental and therapeutic medicine ·doi:10.3892/etm.2018.6840

Fluctuations of interleukin-1β (IL-1β) and heparin-binding epidermal growth factor (HB-EGF) in endometrial receptivity were detected. Seventy-two patients receiving in vitro fertilization-embryo transfer (IVF-ET) for the first time in Yanta…

2018
Frontiers in medicine ·doi:10.3389/fmed.2018.00244

Long non-coding RNAs (lncRNA) are emerging as new genetic/epigenetic regulators that can impact almost all physiological functions. Here, we focus on the long non-coding steroid receptor RNA activator (SRA), including new insights into its …

2018
Oncology letters ·doi:10.3892/ol.2018.9381

Previous studies have reported the upregulation of stem cell biomarkers that are associated with tumorigenesis, in particular with cancer infiltration, recurrence and metastasis. Infection by human papilloma virus (HPV) is the main etiopath…